【序号】：1 【作者】：Knuf M, Kieninger-Baum D, Habermehl P, Muttonen P, Maurer H, Vink P, Poolman J, Boutriau D 【题名】：A dose-range study assessing immunogenicity and safety of one dose of a new candidate meningococcal serogroups A, C, W-135, Y tetanus toxoid conjugate (MenACWY-TT) vaccine administered in the second year of life and in young children 【期刊】：Vaccine. 【年、卷、期、起止页码】：2010 Jan 8;28(3):744-53. Epub 2009 Nov 1 【全文链接】：http://www.ncbi.nlm.nih.gov/pubmed/19887137
【序号】：2 【作者】：Marchant CD, Miller JM, Marshall GS, Blatter M, Aris E, Friedland LR, Boutriau D; HibMenCY-TT 005 Study Group 【题名】：Randomized trial to assess immunogenicity and safety of Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine in infants 【期刊】：Pediatr Infect Dis J. 【年、卷、期、起止页码】：2010 Jan;29(1):48-52 【全文链接】：http://www.ncbi.nlm.nih.gov/pubmed/20035207
【序号】：3 【作者】：Ostergaard L, Lebacq E, Poolman J, Maechler G, Boutriau D 【题名】：Immunogenicity, reactogenicity and persistence of meningococcal A, C, W-135 and Y-tetanus toxoid candidate conjugate (MenACWY-TT) vaccine formulations in adolescents aged 15-25 years 【期刊】：Vaccine. 【年、卷、期、起止页码】：2009 Jan 1;27(1):161-8. Epub 2008 Oct 1 【全文链接】：http://www.ncbi.nlm.nih.gov/pubmed/18834910
【序号】：4 【作者】：Vesikari T, Karvonen A, Bianco V, Van der Wielen M, Miller J. 【题名】：Tetravalent meningococcal serogroups A, C, W-135 and Y conjugate vaccine is well tolerated and immunogenic when co-administered with measles-mumps-rubella-varicella vaccine during the second year of life: An open, randomized controlled trial. 【期刊】：Vaccine. 【年、卷、期、起止页码】：2011 Jun 6;29(25):4274-84. Epub 2011 Apr 6 【全文链接】：http://www.ncbi.nlm.nih.gov/pubmed/21443965
【序号】：5 【作者】：Knuf M, Pantazi-Chatzikonstantinou A, Pfletschinger U, Tichmann-Schumann I, Maurer H, Maurer L, Fischbach T, Zinke H, Pankow-Culot H, Papaevangelou V, Bianco V, Van der Wielen M, Miller JM 【题名】：An investigational tetravalent meningococcal serogroups A, C, W-135 and Y-tetanus toxoid conjugate vaccine co-administered with Infanrix™ hexa is immunogenic, with an acceptable safety profile in 12-23-month-old children 【期刊】：Vaccine 【年、卷、期、起止页码】：2011 Jun 6;29(25):4264-73. Epub 2011 Mar 21 【全文链接】：http://www.ncbi.nlm.nih.gov/pubmed/21420417
我的社区
签到
赛默飞实验室产品焕新计划有奖调研！
【七月征文】不一YOUNG实验“猿”
报名开启：ICS2024第十三届光谱网络会议！
推荐收藏！盘点中药材及饮片检测解决方案
